November 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreNovember 01, 2025
The anti-aging market size is expected to rise from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 01, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreNovember 01, 2025
Projections indicate that, antacids industry is projected to rise from USD 7.47 billion in 2024 to USD 10.33 billion by 2034, reflecting a CAGR of 3.30% over the next decade. The antacids market is growing due to rising acid reflux and GERD cases from sedentary lifestyles, an aging population, and increased R&D for novel formulations. Widely us...
November 01, 2025
According to forecasts, the global active pharmaceutical ingredients market will grow from USD 205.98 billion in 2024 to USD 392.5 billion by 2034, with an expected CAGR of 6.66%. In 2022, North America led the global active pharmaceutical ingredients (API) market with $78.19 billion, while Asia Pacific is set for the fastest growth at 7.08% CAGR t...
November 01, 2025
According to market projections, the huntington's disease treatment sector is expected to grow from USD 664.9 million in 2024 to USD 1409.15 million by 2034, reflecting a CAGR of 7.8%. Huntington's disease treatment focuses on managing symptoms, as there's no cure yet. Medications help control movement issues and mood changes, while therapy support...
November 01, 2025
The global insulin market, projected at USD 29.52 billion in 2024, is expected to reach USD 44.54 billion by 2034, growing at a CAGR of 4.2% over the forecast period. Insulin is a hormone made by the pancreas that helps your body use sugar (glucose) for energy. It acts like a key, unlocking cells so glucose can enter. Without enough insulin, sugar ...
November 01, 2025
The U.S. home infusion therapy industry is projected to rise from USD 18.23 billion in 2024 to USD 36.88 billion by 2034, reflecting a CAGR of 7.3% over the next decade. Home infusion therapy in the U.S. lets patients receive medications like antibiotics, pain management, or nutrition through an IV at home instead of a hospital. It’s a conven...
November 01, 2025
Market insights predict the global sports medicine industry will increase from USD 6.28 billion in 2024 to USD 11.90 billion by 2034, achieving a CAGR of 6.6%. In 2024, body reconstruction products dominated with a 41% market share. Knee injuries led demand, making up 32% of the market. North America remained the top region, commanding a 42% share....
November 01, 2025
According to market projections, the retinitis pigmentosa sector is expected to grow from USD 14.89 billion in 2024 to USD 27.17 billion by 2034, reflecting a CAGR of 6.2%. In 2023, Autosomal Recessive RP dominated with 65% market share, but gene therapy is gaining traction at 23%, bringing new hope. North America leads the market, yet Asia Pacific...
November 01, 2025
According to market projections, the ulcerative colitis treatment sector is expected to grow from USD 10.58 billion in 2024 to USD 15.81 billion by 2034, reflecting a CAGR of 4.1%. The battle against ulcerative colitis is heating up! Pancolitis, the most widespread form, accounted for 34% of cases in 2023. Anti-TNF biologics lead treatment options ...
November 01, 2025
Market insights predict the global rheumatoid arthritis drugs industry will increase from USD 18.69 billion in 2024 to USD 29.31 billion by 2034, achieving a CAGR of 4.6%. Rheumatoid arthritis (RA) drugs help reduce pain, swelling, and joint damage by controlling the immune system’s overactive response. Treatments include NSAIDs for pain, ste...
November 01, 2025
Market insights predict the global nanomedicine industry will increase from USD 241.49 billion in 2024 to USD 632.09 billion by 2034, achieving a CAGR of 10.1%. In 2024, North America led the market, while Asia-Pacific is the fastest-growing region. Drug delivery dominated by application, but therapeutics is set for rapid growth. Clinical oncology ...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com